RxDoctor Payments Data

Ryan McMillan, MD

Otolaryngology · Rochester, MNNPI 1194220194

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,595 of the $1,875 with a category attached, or 85.1%. 6 manufacturers reported payments, led by Acclarent, Inc at 35.0% of the total. Reporting peaked in 2023 at $813 and has fallen 80.6% since, to $158 in 2025.

$1,875in general payments, 2019–2025

Across 18 payments — averaging $104.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$657
  • Inspire Medical Systems, Inc.$433
  • Medical Device Business Services, Inc.$280
  • Stryker$240
  • Aerin Medical Inc.$158
  • Medtronic$108

What the payments were for

  • Food & beverage$1,59585%
  • Education$28015%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,875 in reported general payments places this provider in the 75th percentile of 181 otolaryngology providers in Minnesota.

See all otolaryngology providers in Minnesota

Medicare billing

Part B allowed, 2024
$91,447
Medicare patients
225
Services billed
606

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth18$2,111
Azelastine Hcl83$2,002
Fluticasone Propionate97$1,294
Fluocinolone Acetonide Oil28$1,275
Omeprazole76$1,124
Ipratropium Bromide41$1,110
Ofloxacin25$997
Doxycycline Hyclate60$712
Pantoprazole Sodium22$440
Mupirocin52$371
Methylprednisolone25$235
Famotidine16$222
Cephalexin29$203
Oxycodone Hcl55$166
Prednisone34$127

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →